Edwards Lifesciences Corporation Restructuring Costs and Asset Impairment Charges
Edwards Lifesciences Corporation (EW) reported Restructuring Costs and Asset Impairment Charges of $19.00 million for the 3-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:RestructuringCostsAndAssetImpairmentCharges · last filed 2025-02-28
- Edwards Lifesciences Corporation restructuring costs and asset impairment charges for the quarter ending 2024-12-31 was $19.00M.
- Edwards Lifesciences Corporation restructuring costs and asset impairment charges for the quarter ending 2024-03-31 was $41.30M.
| Period end | Restructuring Costs and Asset Impairment Charges | Restructuring Costs and Asset Impairment Charges 1 month | Restructuring Costs and Asset Impairment Charges 1 month as first filed | Restructuring Costs and Asset Impairment Charges 3 month |
|---|---|---|---|---|
| 2024-12-31 | $19.00M 10-K · filed 2025-02-28 | |||
| 2024-03-31 | $41.30M 10-Q · filed 2024-04-29 | |||
| 2023-12-07 | $17.20M 10-K · filed 2024-02-12 | |||
| 2022-09-30 | $62.30M 10-K · filed 2025-02-28 | $68.40M 10-Q · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |